MENU
KROS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Keros Therapeutics (KROS) Ownership - Who owns Keros Therapeutics?

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs... Show more

Profile

Industry
N/A
Address
1050 Waltham Street
Phone
+1 617 314-6297
Employees
78
Web
https://www.kerostx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
217.51M
P/E Ratio
4.78
Total Cash
281.5M
Projected Growth
N/A
Total Debt
16.31M
Revenue
33.18M
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash/Share
14.22
Total Debt/Equity
N/A
Revenue/Share
1.02 USD as % of share price
View a ticker or compare two or three
KROS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on treatments for rare muscle diseases

Industry Biotechnology

Profile
Details
Industry
N/A
Address
1050 Waltham Street
Phone
+1 617 314-6297
Employees
78
Web
https://www.kerostx.com